<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01053130</url>
  </required_header>
  <id_info>
    <org_study_id>KCH1639</org_study_id>
    <secondary_id>09/H0806/69</secondary_id>
    <nct_id>NCT01053130</nct_id>
  </id_info>
  <brief_title>Weight Loss Interventions in Obese Patients With Stages 3-4 Chronic Kidney Disease: a Randomised Controlled Trial</brief_title>
  <official_title>The Effect of Weight Loss Surgery on Preservation of Kidney Function and Cardiovascular Disease Risk Factors in Obese Patients With Stages 3-4 Chronic Kidney Disease: a Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King's College Hospital NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>King's College Hospital NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Weight loss surgery is the most effective weight loss treatment available, but the direct&#xD;
      effect on chronic kidney disease is less widely understood. Early research shows some&#xD;
      improvement in kidney function may occur and candidacy for kidney transplantation can be&#xD;
      improved with weight loss following surgery. To date, no randomised controlled trial has been&#xD;
      performed to examine the effect of weight loss surgery on the progression of chronic kidney&#xD;
      disease.&#xD;
&#xD;
      This randomised trial will allocate patients to either lifestyle modification with diet,&#xD;
      exercise and pharmacotherapy, or weight loss surgery to remove two thirds of the stomach&#xD;
      using the laparoscopic sleeve gastrectomy procedure. This study aims to evaluate weight loss&#xD;
      surgery vs lifestyle modification in patients with chronic kidney disease with estimated&#xD;
      kidney function of 20-60% and morbid obesity (BMI 35-45) in terms of kidney function,&#xD;
      cardiovascular disease risk factors and all-cause mortality.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measured glomerular filtration rate (renal function) using the iohexol clearance method in patients with stages 3-4 chronic kidney disease</measure>
    <time_frame>0, 6, 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite end point of death and cardiovascular outcomes (stroke, myocardial infarction or congestive heart failure hospitalisation)</measure>
    <time_frame>0, 6, 12, 24, 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life and anxiety and depression assessment</measure>
    <time_frame>0, 6, 12, 24, 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary albumin to creatinine ratio and protein to creatinine ratio</measure>
    <time_frame>0, 6, 12, 24, 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition (weight, BMI, waist and hip circ, BIA)</measure>
    <time_frame>0, 6, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance (HOMA method)</measure>
    <time_frame>0, 6, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum adiponectin, leptin, IL-6, TNF-α, hs-CRP, fetuin a</measure>
    <time_frame>0, 6, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary markers IL-6, MCP-1, IL-1β, RBP, NAG</measure>
    <time_frame>0, 6, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial function (flow mediated dilatation)</measure>
    <time_frame>0, 6, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>weight loss surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>laparoscopic sleeve gastrectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lifestyle Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diet and exercise with or without pharmacotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic sleeve gastrectomy</intervention_name>
    <description>laparoscopic sleeve gastrectomy plus dietary and physical activity support</description>
    <arm_group_label>weight loss surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>weight management program</intervention_name>
    <description>1200-1500 kcal renal diet, increased physical activity, with optional orlistat therapy at 120 mg tds for 12 months</description>
    <arm_group_label>Lifestyle Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Stages 3-4 CKD patients (GFR 20-60 mL/min)&#xD;
&#xD;
          -  Male or female&#xD;
&#xD;
          -  BMI 35-45 kg/m2&#xD;
&#xD;
          -  Aged &gt;18 years&#xD;
&#xD;
          -  Previously attempted weight loss&#xD;
&#xD;
          -  Fit or anesthesia and surgery&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  History of chronic liver disease&#xD;
&#xD;
          -  Previous gastric surgery or large hiatus hernia&#xD;
&#xD;
          -  Previous bariatric surgery&#xD;
&#xD;
          -  Psychiatric illness, including anxiety, mood and untreated eating disorders&#xD;
&#xD;
          -  Malnutrition (assessed by subjective global assessment)&#xD;
&#xD;
          -  Infection or course of antibiotics within the last month&#xD;
&#xD;
          -  Unwilling to consider surgical treatment&#xD;
&#xD;
          -  Previous kidney transplant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <study_first_submitted>January 20, 2010</study_first_submitted>
  <study_first_submitted_qc>January 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2010</study_first_posted>
  <last_update_submitted>June 8, 2016</last_update_submitted>
  <last_update_submitted_qc>June 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 9, 2016</last_update_posted>
  <responsible_party>
    <name_title>Miss Helen MacLaughlin</name_title>
    <organization>King's College Hospital NHS Foundation Trust</organization>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>bariatric surgery</keyword>
  <keyword>chronic kidney disease</keyword>
  <keyword>weight loss</keyword>
  <keyword>exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

